LON:VER Vernalis (VER) Share Price, News & Analysis → Warning: this could blow your mind (From DTI) (Ad) Free VER Stock Alerts GBX 6.17 0.00 (0.00%) (As of 10/10/2018) Add Compare Share Share Today's Range 6.17▼ 6.1750-Day Range 6.17▼ 6.1752-Week Range 2.80▼ 14Volume11,076 shsAverage Volume1.22 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Vernalis alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Vernalis Stock (LON:VER)Vernalis plc, a commercial stage pharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products for various medical disorders. The company markets Tuzistra XR for the U.S. prescription cough-cold market; Moxatag, a once-a-day formulation of amoxicillin antibiotic for the treatment of tonsillitis and pharyngitis secondary to streptococcus pyogenes in adults and pediatric patients; and frovatriptan for the acute treatment of migraine. It is also has licensing agreement to develop and commercialize various products focused on the U.S. prescription cough-cold market. In addition, the company is developing V158866, a fatty acid amide hydrolase inhibitor for the treatment of pain; CPI-444, an adenosine A2A receptor antagonist, which is in Phase I/Ib clinical trial to treat patients with various solid tumors; and AUY922, an intravenous Hsp90 inhibitor for treating cancer, as well as CHR2797, an oral aminopeptidase inhibitor for acute myeloid leukemia and myelodysplastic syndrome under Phase II trial. Further, it is developing S55746, a selective Bcl-2 inhibitor that is in Phase I study for the treatment of cancer; V158411 molecule; and RPL554, a novel long-acting inhibitor under Phase II clinical trial for treating inflammatory respiratory diseases. The company has collaborations with Asahi Kasei Pharma; Endo Pharmaceuticals Inc.; Biogen Idec; Lundbeck A/S; Menarini International Operations Luxembourg SA; Novartis Institute for Biomedical Research Inc.; Novartis Pharma AG; Servier Research Group; GlaxoSmithKline plc; Genentech; and Tris Pharma Inc. Vernalis plc was incorporated in 1988 and is headquartered in Winnersh, the United Kingdom.Read More VER Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VER Stock News HeadlinesMarch 27, 2024 | msn.com'Just staggering': UN says households waste 1b meals a dayMarch 17, 2024 | msn.comElvish Yadav case: What is snake venom and its lethal side as recreational drug?March 29, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 17, 2024 | msn.comDr. Kevin Korus: February showers bring March flowersFebruary 18, 2024 | msn.comBest winter flowers for scent – 12 uplifting plants to growJanuary 23, 2024 | msn.comHow does your car insurance rate compare to other cities in California?December 27, 2023 | msn.comBack to the yearly grind: San Francisco holds first holiday tree recycling event since COVIDDecember 26, 2023 | sfgate.comAnnual Chipping Of Christmas Trees Event Held For First Time After 3-Year HiatusMarch 29, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…December 26, 2023 | cbsnews.comSan Francisco Christmas-tree chipping event held for first time in 3 yearsDecember 24, 2023 | msn.comWitch hazel plant care – how to grow this winter-flowering shrub in your backyardDecember 23, 2023 | news.yahoo.comCharging lithium ion batteries sparked Maryland house fire that caused $500K in damage: investigatorsDecember 2, 2023 | usnews.comHow Food and Agriculture Contribute to Climate ChangeDecember 2, 2023 | reuters.comFACTBOX How food and agriculture contribute to climate changeNovember 30, 2023 | finance.yahoo.comCough Suppressant Market is expected to US$ 50,948.51 Million by 2034: Future Market Insights, Inc.November 23, 2023 | msn.comNine ways you’re composting wrong, according to Bay Area expertsNovember 16, 2023 | msn.comStanislaus-area high school students learn how to land $100K-plus construction jobsNovember 7, 2023 | msn.comDoes snake venom really give a high? The answer will surprise youNovember 3, 2023 | msn.comElvish Yadav case: Lethal side of snake venom as a 'recreational drug'November 3, 2023 | msn.comWhy Snake Venom Is Popular At Rave Parties? Everything You Need To KnowOctober 17, 2023 | msn.comWoman rescued from San Joaquin River after crash has diedOctober 17, 2023 | msn.comWoman rescued from San Joaquin River after SUV crash has died, officials sayOctober 12, 2023 | msn.comMan who helped save woman, child from San Joaquin River found deadOctober 11, 2023 | msn.comBody recovered in search for good Samaritan who helped in San Joaquin River rescueOctober 11, 2023 | msn.comSearch continues for man who helped save woman, child from San Joaquin RiverOctober 11, 2023 | msn.comBystander who helped save woman, child from San Joaquin River unaccounted forOctober 11, 2023 | msn.comWoman, child rescued by bystanders from car crash into San Joaquin RiverSee More Headlines Receive VER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vernalis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/12/2017Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:VER CUSIPN/A CIKN/A Webwww.vernalis.com Phone+44-118-9380000FaxN/AEmployees350Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Ian R. Garland (Age 52)CEO & Exec. Director Mr. David MacKney (Age 50)CFO & Exec. Director Ms. Susan WallcraftGroup Gen. Counsel & Company Sec.Mr. Joseph CannyVP of MarketingMs. Donna RadzikSr. VP of Pharmaceutical Quality OperationsKey CompetitorsAbzenaLON:ABZAAPR EnergyLON:APRCambian GroupLON:CMBNPremaitha HealthLON:NIPTSinclair PharmaLON:SPHView All Competitors VER Stock Analysis - Frequently Asked Questions How have VER shares performed in 2024? Vernalis' stock was trading at GBX 6.17 at the beginning of the year. Since then, VER shares have increased by 0.0% and is now trading at GBX 6.17. View the best growth stocks for 2024 here. How were Vernalis' earnings last quarter? Vernalis plc (LON:VER) released its quarterly earnings results on Tuesday, September, 12th. The company reported ($4.10) earnings per share for the quarter, beating analysts' consensus estimates of ($4.50) by $0.40. The business earned $20.79 million during the quarter. What other stocks do shareholders of Vernalis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vernalis investors own include Lloyds Banking Group (LLOY), Filtronic (FTC), Entain PLC (GVC.L) (GVC), Oxford Biomedica (OXB), Assura (AGR), Arsanis (ASNS), Bertrandt Aktiengesellschaft (BDT), BP (BP) and Cummins (CMI). How do I buy shares of Vernalis? Shares of VER stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:VER) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vernalis plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.